Epac has been found to potentiate growth arrest and apoptosis initiated by BCR signaling in immature B cell lymphoma (WEHI-231 cell line) (Figure 4B) [48]. This evidence concerns the gene RAPGEF3 and B-cell non-Hodgkin lymphoma.